Chairman Emeritus of Pediatrics
Duke University School of Medicine
Samuel L. Katz, MD is an American pediatrician and virologist whose career has been devoted to infectious disease research, focusing principally on vaccine research and development. Dr. Katz is currently the Wilburt Cornell Davison Professor and Chairman Emeritus of Pediatrics at Duke University.
Dr. Katz is an honors graduate of Dartmouth College and Harvard Medical School. After a medical internship at Beth Israel Hospital, he completed pediatrics residency training at Massachusetts General Hospital and Boston Children's Hospital, followed by a research fellowship in virology and infectious diseases. He then became a staff member at Children's Hospital working with Nobel Laureate John F. Enders. He remained with Enders for 12 years during which time they developed the attenuated measles virus vaccine now used throughout the world. In addition to his work on measles, Dr. Katz has been involved in studies of many other pathogens and infectious diseases, including vaccinia, polio, rubella, influenza, pertussis, HIV, and Haemophilus influenzae b conjugates.
Dr. Katz has chaired the Committee on Infectious Diseases of the American Academy of Pediatrics (the Redbook Committee), the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control, the Vaccine Priorities Study of the Institute of Medicine (IOM), and several World Health Organization (WHO) and CVI vaccine and HIV panels. He is a member of many scientific advisory committees and boards, including the National Institutes of Health (NIH), the IOM, and the WHO. He was Chairman of the Public Policy Council of the Infectious Diseases Society of America (IDSA) and currently co-chairs IDSA's Vaccine Initiative.
Dr. Katz was the 2003 winner of the Albert B. Sabin Gold Medal awarded by the Sabin Vaccine Institute for his contributions to vaccine discoveries during his career.
He holds honorary degrees from Georgetown University and Dartmouth College.
Dr. Katz is currently working on the Measles-Rubella Initiative to develop vaccine programs for resource-poor nations, especially sub-Saharan Africa.